Artemis Medicare Services Share Price
Sector: Healthcare Facilities
249.85 -0.95 (-0.38%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
248.40
Today’s High
255.85
52 Week Low
144.50
52 Week High
348.30
250.65 -0.35 (-0.14%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
248.00
Today’s High
255.10
52 Week Low
143.05
52 Week High
350.00
Key Metrics
- Market Cap (In Cr) 3456.38
- Beta 1.8
- Div. Yield (%) 0.18
- P/B 4.12
- TTM P/E 51.11
- Peg Ratio 1.46
- Sector P/E 22.75
- D/E 0
- Open Price 255.85
- Prev Close 250.8
Artemis Medicare Services Analysis
Price Analysis
-
1 Week0.32%
-
3 Months-7.63%
-
6 Month-13.33%
-
YTD-20.38%
-
1 Year37.53%
Risk Meter
- 45% Low risk
- 45% Moderate risk
- 45% Balanced Risk
- 45% High risk
- 45% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 2
- 2
- Buy
- 1
- 1
- 0.00
- 0.00
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 2
- 2
- 2
- 2
Artemis Medicare Services News
Multibagger pharma stock close to record high after rising 1000% in four years
2 min read . 09 Aug 2024Stock market today: Five stocks to buy or sell on Tuesday — July 30
4 min read . 30 Jul 2024Stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks today
2 min read . 12 Jul 2024Stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks today
2 min read . 10 May 2024Artemis Medicare Services Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 936.92
- Selling/ General/ Admin Expenses Total
- 148.37
- Depreciation/ Amortization
- 45.16
- Other Operating Expenses Total
- 636.75
- Total Operating Expense
- 830.29
- Operating Income
- 106.62
- Net Income Before Taxes
- 107.67
- Net Income
- 82.63
- Diluted Normalized EPS
- 5.31
- Period
- 2025
- Total Assets
- 1357.41
- Total Liabilities
- 519.73
- Total Equity
- 837.68
- Tangible Book Valueper Share Common Eq
- 57.12
- Period
- 2025
- Cashfrom Operating Activities
- 145.62
- Cashfrom Investing Activities
- -385.38
- Cashfrom Financing Activities
- 266.75
- Net Changein Cash
- 26.98
- Period
- 2024
- Total Revenue
- 878.57
- Selling/ General/ Admin Expenses Total
- 182.33
- Depreciation/ Amortization
- 40.32
- Other Operating Expenses Total
- 541.73
- Total Operating Expense
- 786.13
- Operating Income
- 92.44
- Net Income Before Taxes
- 68.45
- Net Income
- 49.14
- Diluted Normalized EPS
- 3.52
- Period
- 2024
- Total Assets
- 971.51
- Total Liabilities
- 523.16
- Total Equity
- 448.35
- Tangible Book Valueper Share Common Eq
- 29.42
- Period
- 2024
- Cashfrom Operating Activities
- 223.54
- Cashfrom Investing Activities
- -86.99
- Cashfrom Financing Activities
- -30.12
- Net Changein Cash
- -8.26
- Period
- 2023
- Total Revenue
- 737.43
- Selling/ General/ Admin Expenses Total
- 163.44
- Depreciation/ Amortization
- 31
- Other Operating Expenses Total
- 461.23
- Total Operating Expense
- 674.26
- Operating Income
- 63.17
- Net Income Before Taxes
- 50.61
- Net Income
- 38.6
- Diluted Normalized EPS
- 2.72
- Period
- 2023
- Total Assets
- 904.95
- Total Liabilities
- 501.8
- Total Equity
- 403.15
- Tangible Book Valueper Share Common Eq
- 26.4
- Period
- 2023
- Cashfrom Operating Activities
- 127.16
- Cashfrom Investing Activities
- -158.21
- Cashfrom Financing Activities
- 38.22
- Net Changein Cash
- 7.17
- Period
- 2022
- Total Revenue
- 554.8
- Selling/ General/ Admin Expenses Total
- 127.2
- Depreciation/ Amortization
- 22.19
- Other Operating Expenses Total
- 342.53
- Total Operating Expense
- 509.02
- Operating Income
- 45.78
- Net Income Before Taxes
- 37.18
- Net Income
- 31.81
- Diluted Normalized EPS
- 2.32
- Period
- 2022
- Total Assets
- 709.66
- Total Liabilities
- 350.24
- Total Equity
- 359.42
- Tangible Book Valueper Share Common Eq
- 23.69
- Period
- 2022
- Cashfrom Operating Activities
- 59.58
- Cashfrom Investing Activities
- -107.22
- Cashfrom Financing Activities
- 44.18
- Net Changein Cash
- -3.46
- Period
- 2021
- Total Revenue
- 408.4
- Selling/ General/ Admin Expenses Total
- 256.51
- Depreciation/ Amortization
- 21.51
- Total Operating Expense
- 391.25
- Operating Income
- 17.16
- Net Income Before Taxes
- 7.53
- Net Income
- 6.49
- Diluted Normalized EPS
- 0.3
- Period
- 2021
- Total Assets
- 600.09
- Total Liabilities
- 279.9
- Total Equity
- 320.19
- Tangible Book Valueper Share Common Eq
- 20.84
- Period
- 2021
- Cashfrom Operating Activities
- 27.26
- Cashfrom Investing Activities
- -37.42
- Cashfrom Financing Activities
- 17.72
- Net Changein Cash
- 7.55
- Period
- 2020
- Total Revenue
- 565.02
- Selling/ General/ Admin Expenses Total
- 364.38
- Depreciation/ Amortization
- 22.63
- Total Operating Expense
- 526.05
- Operating Income
- 38.97
- Net Income Before Taxes
- 30.63
- Net Income
- 19.79
- Diluted Normalized EPS
- 1.51
- Period
- 2020
- Total Assets
- 586.44
- Total Liabilities
- 273.2
- Total Equity
- 313.24
- Tangible Book Valueper Share Common Eq
- 20.26
- Period
- 2020
- Cashfrom Operating Activities
- 56.08
- Cashfrom Investing Activities
- -26.29
- Cashfrom Financing Activities
- -27.42
- Net Changein Cash
- 2.37
- Period
- 2019
- Total Revenue
- 546.52
- Selling/ General/ Admin Expenses Total
- 97.28
- Depreciation/ Amortization
- 20.07
- Other Operating Expenses Total
- 254.84
- Total Operating Expense
- 502.78
- Operating Income
- 43.74
- Net Income Before Taxes
- 36.74
- Net Income
- 20.49
- Diluted Normalized EPS
- 1.55
- Period
- 2019
- Period
- 2019
- Period
- 2025-03-31
- Total Revenue
- 239.9
- Selling/ General/ Admin Expenses Total
- 39.14
- Depreciation/ Amortization
- 11.74
- Other Operating Expenses Total
- 164.86
- Total Operating Expense
- 215.75
- Operating Income
- 24.15
- Net Income Before Taxes
- 28.66
- Net Income
- 23.03
- Diluted Normalized EPS
- 1.45
- Period
- 2025-03-31
- Total Assets
- 1357.41
- Total Liabilities
- 519.73
- Total Equity
- 837.68
- Tangible Book Valueper Share Common Eq
- 57.12
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 145.62
- Cashfrom Investing Activities
- -385.38
- Cashfrom Financing Activities
- 266.75
- Net Changein Cash
- 26.98
- Period
- 2024-12-31
- Total Revenue
- 232.39
- Selling/ General/ Admin Expenses Total
- 37.47
- Depreciation/ Amortization
- 11.45
- Other Operating Expenses Total
- 157.46
- Total Operating Expense
- 206.38
- Operating Income
- 26.01
- Net Income Before Taxes
- 26.81
- Net Income
- 20.67
- Diluted Normalized EPS
- 1.31
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 241.42
- Selling/ General/ Admin Expenses Total
- 35.87
- Depreciation/ Amortization
- 11.17
- Other Operating Expenses Total
- 163.29
- Total Operating Expense
- 210.33
- Operating Income
- 31.09
- Net Income Before Taxes
- 30.55
- Net Income
- 22.26
- Diluted Normalized EPS
- 1.41
- Period
- 2024-09-30
- Total Assets
- 1339.05
- Total Liabilities
- 546.54
- Total Equity
- 792.51
- Tangible Book Valueper Share Common Eq
- 53.96
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 69.22
- Cashfrom Investing Activities
- -361.9
- Cashfrom Financing Activities
- 291.71
- Net Changein Cash
- -0.96
- Period
- 2024-06-30
- Total Revenue
- 223.2
- Selling/ General/ Admin Expenses Total
- 35.89
- Depreciation/ Amortization
- 10.8
- Other Operating Expenses Total
- 151.14
- Total Operating Expense
- 197.83
- Operating Income
- 25.37
- Net Income Before Taxes
- 21.64
- Net Income
- 16.67
- Diluted Normalized EPS
- 1.12
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 225.24
- Selling/ General/ Admin Expenses Total
- 36.06
- Depreciation/ Amortization
- 11.04
- Other Operating Expenses Total
- 151.23
- Total Operating Expense
- 198.33
- Operating Income
- 26.91
- Net Income Before Taxes
- 20.24
- Net Income
- 14.18
- Diluted Normalized EPS
- 1.02
- Period
- 2024-03-31
- Total Assets
- 971.51
- Total Liabilities
- 523.16
- Total Equity
- 448.35
- Tangible Book Valueper Share Common Eq
- 29.42
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 230.13
- Cashfrom Investing Activities
- -86.99
- Cashfrom Financing Activities
- -30.12
- Net Changein Cash
- -8.26
- Period
- 2023-12-31
- Total Revenue
- 218.78
- Selling/ General/ Admin Expenses Total
- 34.69
- Depreciation/ Amortization
- 10.16
- Other Operating Expenses Total
- 151.45
- Total Operating Expense
- 196.3
- Operating Income
- 22.48
- Net Income Before Taxes
- 16.31
- Net Income
- 11.55
- Diluted Normalized EPS
- 0.83
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Artemis Medicare Services Technical
Moving Average
SMA
- 5 Day247.51
- 10 Day244.87
- 20 Day256.82
- 50 Day256.76
- 100 Day277.89
- 300 Day280.3
Artemis Medicare Services Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Thyrocare Technologies
- 980.45
- 31
- 3.27
- 1053.05
- 570.75
- 5194.94
- Indraprastha Medical Corp
- 421
- 3.25
- 0.78
- 571.95
- 212.25
- 3870.63
- Artemis Medicare Services
- 249.85
- -0.95
- -0.38
- 348.3
- 144.5
- 3456.38
- Shalby
- 201.5
- 1.8
- 0.9
- 325
- 177.25
- 2166.05
- Dr. Agarwal's Eye Hospital
- 4370
- -27.9
- -0.63
- 7300
- 2800
- 2054.22
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Thyrocare Technologies
- 55.81
- 9.24
- 20.87
- 17.91
- Indraprastha Medical Corp
- 30.66
- 8.01
- 19.59
- 6.73
- Artemis Medicare Services
- 47.27
- 4.12
- 9.91
- 5.88
- Shalby
- 25.58
- 2.15
- 6.37
- 8.2
- Dr. Agarwal's Eye Hospital
- 44.42
- 13.15
- 29.64
- 10.83
Artemis Medicare Services Shareholding
Shareholding Pattern
*Promoter pledging: 29.91%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-May-25
- Audited Results & Final Dividend
- 05-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 10-May-24
- Audited Results & Final Dividend
- 05-Apr-24
- Others
- 05-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 08-Aug-23
- Quarterly Results
- 05-May-23
- Audited Results & Dividend
- Meeting Date
- Announced on
- Purpose
- 28-Dec-24
- 26-Nov-24
- POM
- 11-Sept-24
- 12-Aug-24
- POM
- 24-Jul-24
- 18-Jun-24
- AGM
- 01-Aug-23
- 05-May-23
- AGM
- 20-Mar-23
- 16-Feb-23
- POM
- 13-Jul-22
- 04-Jun-22
- AGM
- 11-Sept-21
- 10-Aug-21
- POM
- 20-Jul-21
- 07-Jun-21
- AGM
- 16-Mar-21
- 12-Feb-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 12-May-25
- -
- -
- 0.45
- 10-May-24
- 05-Jul-24
- 05-Jul-24
- 0.45
- 05-May-23
- 14-Jul-23
- 14-Jul-23
- 0.45

- Ex-Splits
- Old FV
- New FV
- Description
- 23-Sept-21
- 10
- 1
- Stock split from Rs. 10/- to Re. 1/-.
